128 related articles for article (PubMed ID: 27055430)
1. [X-linked lymphoproliferative syndrome type 1 complicated with secondary hemophagocytic lymphohistiocytosis and ileal perforation: case report and literature review].
Xiao L; Guan XM; Meng Y; Zhao XD; Xian Y; An YF; Yu J
Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):290-3. PubMed ID: 27055430
[TBL] [Abstract][Full Text] [Related]
2. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
[No Abstract] [Full Text] [Related]
3. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
Jin YY; Zhou W; Tian ZQ; Chen TX
Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
[TBL] [Abstract][Full Text] [Related]
4. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
[TBL] [Abstract][Full Text] [Related]
5. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
[TBL] [Abstract][Full Text] [Related]
6. X-linked Lymphoproliferative Disease Type 1 in a Patient With the p.Gly93Asp SH2D1A Gene Mutation and Hemophagocytic Lymphohistiocytosis.
de la Varga-Martínez R; Mora-López F; García-Cuesta D; Garrastazul-Sánchez MP; Quintero S; Rodríguez C; Sampalo A
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e483-e485. PubMed ID: 28816794
[TBL] [Abstract][Full Text] [Related]
7. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
[TBL] [Abstract][Full Text] [Related]
8. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency.
Wada T; Kanegane H; Ohta K; Katoh F; Imamura T; Nakazawa Y; Miyashita R; Hara J; Hamamoto K; Yang X; Filipovich AH; Marsh RA; Yachie A
Cytokine; 2014 Jan; 65(1):74-8. PubMed ID: 24084330
[TBL] [Abstract][Full Text] [Related]
9. SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis.
Yang X; Miyawaki T; Kanegane H
Pediatr Int; 2012 Aug; 54(4):447-54. PubMed ID: 22672194
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel nonsense mutation in SH2D1A in a patient with X-linked lymphoproliferative syndrome type 1: a case report.
Lyu X; Guo Z; Li Y; Fan R; Song Y
BMC Med Genet; 2018 Apr; 19(1):60. PubMed ID: 29649976
[TBL] [Abstract][Full Text] [Related]
11. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.
Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG
Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and gene research of X-linked lymphoproliferative disease in a Chinese family].
Zhu DX; Du J; Lan HK; Yu L; Feng ZC
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):244-8. PubMed ID: 17425868
[TBL] [Abstract][Full Text] [Related]
13. Hemophagocytic lymphohistiocytosis in a patient with x-linked lymphoproliferative disease.
Bird JA; McClain KL; Rosenblatt HM; Abramson SL; Hanson IC
Allergy Asthma Proc; 2009; 30(4):458-62. PubMed ID: 19772767
[TBL] [Abstract][Full Text] [Related]
14. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
Pachlopnik Schmid J; Canioni D; Moshous D; Touzot F; Mahlaoui N; Hauck F; Kanegane H; Lopez-Granados E; Mejstrikova E; Pellier I; Galicier L; Galambrun C; Barlogis V; Bordigoni P; Fourmaintraux A; Hamidou M; Dabadie A; Le Deist F; Haerynck F; Ouachée-Chardin M; Rohrlich P; Stephan JL; Lenoir C; Rigaud S; Lambert N; Milili M; Schiff C; Chapel H; Picard C; de Saint Basile G; Blanche S; Fischer A; Latour S
Blood; 2011 Feb; 117(5):1522-9. PubMed ID: 21119115
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome.
Sun J; Ying W; Liu D; Hui X; Yu Y; Wang J; Wang X
Scand J Immunol; 2013 Nov; 78(5):463-7. PubMed ID: 23944711
[TBL] [Abstract][Full Text] [Related]
16. Rare cause of Hemophagocytic Lymphohistiocytosis due to mutation in PRF1 and SH2D1A genes in two children - a case report with a review.
Sheth J; Patel A; Shah R; Bhavsar R; Trivedi S; Sheth F
BMC Pediatr; 2019 Mar; 19(1):73. PubMed ID: 30849948
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic challenges for a novel SH2D1A mutation associated with X-linked lymphoproliferative disease.
Torralba-Raga L; Tesi B; Chiang SCC; Schlums H; Nordenskjöld M; Horne A; Henter JI; Meeths M; Abdelhaleem M; Weitzman S; Bryceson Y
Pediatr Blood Cancer; 2020 Apr; 67(4):e28184. PubMed ID: 31994322
[TBL] [Abstract][Full Text] [Related]
18. Potential pathogenic mechanism of type 1 X-linked lymphoproliferative syndrome caused by a mutation of SH2D1A gene in an infant: A case report.
Wang Y; Wang Y; Lu W; Tao L; Xiao Y; Zhou Y; He X; Zhang Y; Li L
Medicine (Baltimore); 2022 Oct; 101(41):e30951. PubMed ID: 36254040
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencing.
Ono S; Nakayama M; Kanegane H; Hoshino A; Shimodera S; Shibata H; Fujino H; Fujino T; Yunomae Y; Okano T; Yamashita M; Yasumi T; Izawa K; Takagi M; Imai K; Zhang K; Marsh R; Picard C; Latour S; Ohara O; Morio T
Int J Hematol; 2018 Sep; 108(3):319-328. PubMed ID: 29777376
[TBL] [Abstract][Full Text] [Related]
20. X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective.
Panchal N; Booth C; Cannons JL; Schwartzberg PL
Front Immunol; 2018; 9():666. PubMed ID: 29670631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
